Neuromuscular Electrical Stimulation on Patellofemoral Pain

October 19, 2019 updated by: Jamilson Simões Brasileiro, Universidade Federal do Rio Grande do Norte

Effects of a Neuromuscular Electrical Stimulation Protocol in Women With Patellofemoral Pain

Objective this study is to analyze the effects of an intervention protocol with neuromuscular electrical stimulation in the vastus medialis obliquus and gluteus medius (GM) associated with exercises on electromyographic activity, muscle performance, self-reported functionality and pain of women with patellofemoral pain.

Study Overview

Detailed Description

This is a randomized, blinded trial in which 40 women, aged 18-30 years, will be randomized into 2 groups: Stimulation and Exercise Group (SEG) - will perform an exercise protocol associated with stimulation in the vastus medialis (VM) and gluteus medius (GM) muscles. Exercises Group (ExG) - will perform the same protocol of exercises of the previous group, however, without association with neuromuscular electrical stimulation. The intervention will occur twice a week for eight weeks. All volunteers will be submitted to the evaluation of the electromyographic activity of the VM, the GM and the vastus lateralis, the dynamometric parameters, the intensity of the pain and the functionality, in four moments: 72h hours before the beginning of the intervention; after 4 weeks of intervention; after 8 weeks of intervention; after 16 weeks from the start of the intervention (eight weeks after the end of the protocol). In this way, the investigators will investigate the applicability of the proposed trial with the use of neuromuscular electrical stimulation and identify the effects of this resource in the treatment of PFP.

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • RN
      • Natal, RN, Brazil, 59140-840
        • Recruiting
        • Federal University of Rio Grande do Norte
        • Contact:
    • Rio Grande Do Norte
      • Natal, Rio Grande Do Norte, Brazil, 59078-970
        • Recruiting
        • Universidade Federal do Rio Grande do Norte
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Present anterior or retropatellar pain during at least two of the following functional activities: sitting for long periods, going up or down stairs, running, kneeling down, crouching or jumping;
  • A minimum pain score of three on the numerical pain scale, at the last 24 hours, with insidious and non-traumatic onset of symptoms for at least one month.

Exclusion Criteria:

  • History of surgery, trauma or an osteomioarticular system injury in the lower limbs in the last six months;
  • Other pathology associated with the knee joint and could not have performed physical therapy treatment in the last twelve weeks;
  • Body mass index greater than 30;
  • Pregnancy or breastfeeding;
  • Contraindications for the application of neuromuscular electrical stimulation;
  • Intolerance or non-acceptance of electric current;
  • Missing more than two intervention sessions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neuromuscular electrical stimulation
8-week exercise program, twice a week, with neuromuscular eletrical stimulation on vastus medialis and gluteus medius.
Exercise protocol associated with neuromuscular electrical stimulation on vastus medialis and gluteus medius. Parameters: rectangular pulse shape, biphasic, symmetrical, pulse duration of 200μs, interbust interval of 10ms and frequency of 2.500Hz modulated in 50 bursts.
Other Names:
  • Muscular eletrical stimulation
Active Comparator: Exercise
8-week exercise program, twice a week.
Same protocol of exercises of the other group, without association of electrical stimulation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee pain
Time Frame: Change from baseline in knee pain at 8 weeks.
Evaluation of pain level in the knee using the Numerical Pain Scale, graded from 0 to 10, where 0 indicates absence of pain and 10 indicates the worst pain imaginable.
Change from baseline in knee pain at 8 weeks.
Knee function
Time Frame: Change from baseline in knee function at 8 weeks.
Evaluation of knee function using the Anterior Knee Pain Scale, that is a questionnaire encompassing 13 items related to different levels of knee function, with scores ranging from zero (representing the highest possible deficit) to 100 (meaning that the subject does not present any deficit).
Change from baseline in knee function at 8 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Root Mean Square (RMS)
Time Frame: Change from baseline in RMS at 8 weeks.
Evaluation of the amplitude oh the electromyographic sinal (RMS) of vastus medialis, vastus lateralis and gluteus medius.
Change from baseline in RMS at 8 weeks.
Time of muscle activation (Onset)
Time Frame: Change from baseline in onset of the electromyographic at 8 weeks.
Evaluation of time of muscle activation electromyographic (onset) of vastus medialis, vastus lateralis and gluteus medius.
Change from baseline in onset of the electromyographic at 8 weeks.
Isokinetic performance
Time Frame: Change from baseline in peak torque normalized for body weight at 8 weeks.
Evaluation of isokinetic variable peak torque normalized for body weight (%) of knee extensors and hip abductors.
Change from baseline in peak torque normalized for body weight at 8 weeks.
Isokinetic performance
Time Frame: Change from baseline in average peak torque at 8 weeks.
Evaluation of isokinetic variable average peak torque (Nm) of knee extensors and hip abductors.
Change from baseline in average peak torque at 8 weeks.
Isokinetic performance
Time Frame: Change from baseline in average power at 8 weeks.
Evaluation of isokinetic variable average power (W) of knee extensors and hip abductors.
Change from baseline in average power at 8 weeks.
Isokinetic performance
Time Frame: Change from baseline in total work at 8 weeks.
Evaluation of isokinetic variable total work (J) of knee extensors and hip abductors.
Change from baseline in total work at 8 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jamilson S Brasileiro, PhD, Universidade Federal do Rio Grande do Norte

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2019

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

April 2, 2019

First Submitted That Met QC Criteria

April 16, 2019

First Posted (Actual)

April 18, 2019

Study Record Updates

Last Update Posted (Actual)

October 22, 2019

Last Update Submitted That Met QC Criteria

October 19, 2019

Last Verified

May 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • SAM2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on Neuromuscular electrical stimulation

Subscribe